Detalles de la búsqueda
1.
Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-ß.
Eur J Nucl Med Mol Imaging
; 2024 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38888612
2.
Combined inhibition of bile salt synthesis and intestinal uptake reduces cholestatic liver damage and colonic bile salts in mice.
JHEP Rep
; 6(1): 100917, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38074508
3.
Donor T cells administered over HLA class II barriers mediate antitumor immunity without broad off-target toxicity in a NOD/scid mouse model of acute leukemia.
Biol Blood Marrow Transplant
; 19(6): 867-75, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23500532
4.
A mechanistic rationale for combining alemtuzumab and rituximab in the treatment of ALL.
Blood
; 116(26): 5930-40, 2010 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-20844239
5.
Early detection and rapid isolation of leukemia-reactive donor T cells for adoptive transfer using the IFN-gamma secretion assay.
Clin Cancer Res
; 13(2 Pt 1): 636-43, 2007 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17255287
6.
Limited antitumor-effect associated with toxicity of the experimental cytotoxic drug cyclopentenyl cytosine in NOD/scid mice with acute lymphoblastic leukemia.
Leuk Res
; 31(11): 1545-51, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17459472
7.
Complement-dependent cytotoxicity induced by therapeutic antibodies in B-cell acute lymphoblastic leukemia is dictated by target antigen expression levels and augmented by loss of membrane-bound complement inhibitors.
Leuk Lymphoma
; 58(9): 1-14, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28140725
8.
Responses to donor lymphocyte infusion for acute lymphoblastic leukemia may be determined by both qualitative and quantitative limitations of antileukemic T-cell responses as observed in an animal model for human leukemia.
Exp Hematol
; 33(10): 1172-81, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16219539
9.
Differential effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway in acute lymphoblastic leukemia.
PLoS One
; 8(11): e80070, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24244612
10.
Imatinib mesylate at therapeutic doses has no impact on folliculogenesis or spermatogenesis in a leukaemic mouse model.
Leuk Res
; 36(3): 271-4, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22018447
11.
Long-term culture of primary human lymphoblastic leukemia cells in the absence of serum or hematopoietic growth factors.
Exp Hematol
; 37(3): 376-85, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19135770
12.
Establishment and cytogenetic characterization of a human acute lymphoblastic leukemia cell line (ALL-VG) with ETV6/ABL1 rearrangement.
Cancer Genet Cytogenet
; 185(1): 37-42, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18656692
13.
An animal model for human cellular immunotherapy: specific eradication of human acute lymphoblastic leukemia by cytotoxic T lymphocytes in NOD/scid mice.
Blood
; 100(2): 654-60, 2002 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12091361
Resultados
1 -
13
de 13
1
Próxima >
>>